A novel prognostic score of recurrence for endometrial cancer patients with staging surgery.

ABSTRACT:

Background

Recently, there have been an increasing number of reports on the association between inflammatory markers and the prognosis of malignant tumors. However, the current inflammatory indicators have limited accuracy. We aimed to develop a new scoring system for predicting endometrial cancer recurrence using inflammatory markers, tumor markers, and histological diagnoses.

Methods

Patients with primary, previously untreated, and suspected endometrial cancer who underwent surgery at the Nara Medical University Hospital between January 2007 and December 2020 were included and followed up until March 2024. Items were divided into positive and negative using scores based on cutoff values and placed into the new scoring system, the endometrial tumor-related (ETR) score.

R

SUBMITTER: Maehana T 

PROVIDER: S-EPMC11684112 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature